发明名称 |
Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
摘要 |
Method of identifying compounds that modulate intermolecular interactions between a target protein and a modifier are disclosed. Pharmaceutical composition comprising compounds that inhibit intermolecular interactions between a target protein and a modifier are disclosed. Methods of treating individual suffering from inflammatory conditions, undesirable immune responses, immunological conditions and bacterial infections are disclosed. |
申请公布号 |
US8785419(B2) |
申请公布日期 |
2014.07.22 |
申请号 |
US201113194832 |
申请日期 |
2011.07.29 |
申请人 |
The Trustees Of The University Of Pennsylvania |
发明人 |
Murali Ramachandran;Greene Mark I. |
分类号 |
A01N33/26;A61K31/655;A01N43/36;A61K31/40;A01N37/28;A61K31/215;A01N47/28;A61K31/17;A61K8/42 |
主分类号 |
A01N33/26 |
代理机构 |
Baker & Hostetler LLP |
代理人 |
Baker & Hostetler LLP |
主权项 |
1. A method of inhibiting CD4-mediated signaling in a subject comprising administering to said subject an effective amount of a compound of Formula (IV), (V), or (VI), or a pharmaceutically acceptable salt thereof. |
地址 |
Philadelphia PA US |